ArticleJournal of cardiothoracic surgery2026
Identification and validation of five hypoxia- and immune-related hub targets in atrial fibrillation.
Article in Journal of cardiothoracic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundAtrial fibrillation (AF) is the most common arrhythmia, with increasing incidence and prevalence. Hypoxia and immune response are closely related to the progression of AF. This study aims to explore hub hypoxia- and immune-related genes associated with AF.
methodsMultiple AF datasets from the Gene Expression Omnibus database were downloaded. Hypoxia- and immune-related genes associated with AF were identified by integrating differential expression analysis, weighted gene co-expression network analysis (WGCNA), and protein-protein interaction (PPI) network. Functional enrichment analysis was used to evaluate the functions of key genes. Immune cell infiltration analysis was conducted using CIBERSORT and xCell. To experimentally validate the identified hub genes, RT-qPCR was performed on whole blood samples collected from healthy controls and AF patients.
resultsA total of 13 crucial hypoxia- and immune-related genes associated with AF were identified. Among them, the expressions of IL6, JUN, FOS, FOSL2, and MAFF were significantly higher in the AF group than in the sinus rhythm (SR) group, which was further validated by RT-qPCR showing increased mRNA expression in clinical whole blood samples from AF patients. Notably, transcription factors JUN, FOS, FOSL2, and MAFF exhibited clear binding peaks at promoter region of IL6. Functional enrichment analysis by GSEA revealed that these five hub genes were simultaneously involved in the cAMP signaling pathway, and four of them (JUN, FOS, FOSL2, and MAFF) were also associated with the calcium signaling pathway, indicating a potential cAMP-dependent Ca²⁺ handling mechanism in AF pathogenesis. Immune cell infiltration analysis further showed that these genes were significantly correlated with differential infiltration of various immune cells, including gamma delta T cells, monocytes, macrophages, neutrophils, and NK cells.
conclusionThis study successfully identified JUN, FOS, IL6, FOSL2, and MAFF as crucial hypoxia- and immune-related genes associated with AF, providing potential new targets for the treatment of AF.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.